featured
ESMO 2017: Three Months of Oxaliplatin-Based Chemotherapy Usually Suffices, With Less Neurotoxicity Than 6 Months, in Stage 3 Colon Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.